Temporary Disabled. :) please Go back HIV and AIDS Treatment & Care www.fgks.org » Address: [go: up one dir, main page] Include Form Remove Scripts Accept Cookies Show Images Show Referer Rotate13 Base64 Strip Meta Strip Title Session Cookies International HIV & AIDS charity DonateFundraising About Us Our Partners Help & Advice Contact Us Facebook Linked in Twitter Newsletter Copyright © AVERT skip to menu HIV and AIDS Treatment & Care back to top HIV/AIDS Treatment and Care A generic version of the antiretroviral drug Zidovudine AZT. People with HIV can live long and healthy lives with access to treatment. Since HIV was first reported substantial progress in the research and development of antiretroviral drugs has been made. There are now more than 20 approved antiretroviral drugs. Despite this, people with HIV face many barriers to accessing affordable, effective HIV treatment. Taking HIV treatment requires effort and commitment as drugs must be taken at exact times each day. Some people may experience serious side-effects or may not respond to certain drugs. Treatment, care and support can help people to adhere to treatment and address any problems they may have with their treatment regimen. This page points to comprehensive information about the antiretroviral drugs used to treat HIV, what is involved when a person begins taking antiretroviral treatment and the global disparities in access to treatment. HIV/AIDS Treatment and Care Topics HIV and AIDS Treatment HIV and AIDS Care HIV and AIDS Drugs Treatment Access HIV/AIDS-related Infections back to top What is HIV antiretroviral drug treatment? This is the main type of treatment for HIV or AIDS. It is not a cure, but it can stop people from becoming ill for many years. The treatment consists of drugs that have to be taken every day for the rest of a person’s life. The aim of antiretroviral treatment is to keep the amount of HIV in the body at a low level. This stops any weakening of the immune system and allows it to recover from any damage that HIV might have caused already. The drugs are often referred to as: antiretrovirals, ARVs, anti-HIV or anti-AIDS drugs. back to top What is combination therapy? Taking two or more antiretroviral drugs at a time is called combination therapy. Taking a combination of three or more anti-HIV drugs is sometimes referred to as Highly Active Antiretroviral Therapy (HAART). If only one drug was taken, HIV would quickly become resistant to it and the drug would stop working. Taking two or more antiretrovirals at the same time vastly reduces the rate at which resistance would develop, making treatment more effective in the long term. Our starting, monitoring and switching HIV treatment page has more about drug resistance. What does combination therapy usually consist of? The most common drug combination given to those beginning treatment consists of two NRTIs combined with either an NNRTI or a "boosted" protease inhibitor. Ritonavir (in small doses) is most commonly used as the booster; it enhances the effects of other protease inhibitors so they can be given in lower doses. An example of a common antiretroviral combination is the two NRTIs zidovudine and lamivudine, combined with the NNRTI efavirenz. Some antiretroviral drugs have been combined into one pill, which is known as a ‘fixed dose combination’. This reduces the number of pills to be taken each day. The choice of drugs to take can depend on a number of factors, including the availability and price of drugs, the number of pills, the side effects of the drugs, the laboratory monitoring requirements and whether there are co-blister packs or fixed dose combinations available. Most people living with HIV in the developing world still have very limited access to antiretroviral treatment and often only receive treatment for the diseases that occur as a result of a weakened immune system. Such treatment has only short-term benefits because it does not address the underlying immune deficiency itself. First and second line therapy At the beginning of treatment, the combination of drugs that a person is given is called first line therapy. If after a while HIV becomes resistant to this combination, or if side effects are particularly bad, then a change to second line therapy is usually recommended. Second line therapy will ideally include a minimum of three new drugs, with at least one from a new class, in order to increase the likelihood of treatment success. Our starting, monitoring and switching HIV treatment page has more information about changing HIV treatment. back to top How many HIV and AIDS drugs are there? There are more than 20 approved antiretroviral drugs but not all are licensed or available in every country. See our drugs table for a comprehensive list of antiretroviral drugs approved by the American Food and Drug Administration. The groups of antiretroviral drugs There are five groups of antiretroviral drugs. Each of these groups attacks HIV in a different way. Antiretroviral drug class Abbreviations First approved to treat HIV How they attack HIV Nucleoside/Nucleotide Reverse Transcriptase Inhibitors NRTIs, nucleoside analogues, nukes 1987 NRTIs interfere with the action of an HIV protein called reverse transcriptase, which the virus needs to make new copies of itself. Non-Nucleoside Reverse Transcriptase Inhibitors NNRTIs, non-nucleosides, non-nukes 1997 NNRTIs also stop HIV from replicating within cells by inhibiting the reverse transcriptase protein. Protease Inhibitors PIs 1995 PIs inhibit protease, which is another protein involved in the HIV replication process. Fusion or Entry Inhibitors 2003 Fusion or entry inhibitors prevent HIV from binding to or entering human immune cells. Integrase Inhibitors 2007 Integrase inhibitors interfere with the integrase enzyme, which HIV needs to insert its genetic material into human cells. NRTIs and NNRTIs are available in most countries. Fusion/entry inhibitors and integrase inhibitors are usually only available in resource-rich countries. Protease inhibitors are generally less suitable for starting treatment in resource-limited settings due to the cost, number of pills which need to be taken, and the particular side effects caused by protease drugs. back to top More information Choosing when to start antiretroviral treatment is a very important decision. Once treatment has begun it must be adhered to, in spite of side effects and other challenges. Many factors must be weighed up when deciding whether to begin treatment, including the results of various clinical tests. These issues are addressed in our starting, monitoring and switching HIV treatment page. email print tweet more Where Next? AVERT.org has more about: Antiretroviral Treatment Treatment Access HIV and Nutrition Back to top Sign up to our Newsletter Donate Disclaimer & Privacy Policy back to top www.avert.org is an information resource to be used for educational purposes only. The information is not intended to serve as a substitute for professional medical advice and we recommend that all decisions about your treatment or products you wish to use should be discussed thoroughly and frankly with your doctor. english español back to content home pageHIV & AIDS Topics Treatment & CareEpidemicGlobal EpidemicAIDS & HIV Around the WorldAIDS : What is AIDS? What causes AIDS?HIV & AIDS NewsHIV : The virus that causes AIDSReflections on the Epidemic World AIDS DayMoney for HIV/AIDSFunding for HIV and AIDS Money for HIV/AIDSPEPFARThe Global Fund How different people are affected by HIV and AIDS Men Who Have Sex with Men (MSM)Children orphaned by HIV and AIDSChildren, HIV and AIDSHIV/AIDS and Vulnerable Groups Prisons, Prisoners and HIV/AIDSTransgender People and HIV/AIDSWomen and HIV/AIDSIssuesHIV & Injecting Drug Users HIV & AIDS Stigma and DiscriminationHIV and AIDS IssuesHIV and Sex WorkHistoryHIV and AIDS HistoryAIDS TimelineHistory of AIDS Up to 1986History of AIDS: 1987-1992History of AIDS: 1993-1997History of AIDS: 1998-2002History of AIDS: 2003-2006History of AIDS: 2007 OnwardsAVERT History History of the HIV and AIDS Charity AVERT AVERT: Early 1990s to the start of the InternetAVERT: Overseas projects & developing AVERT.orgAVERT: Southern African projects and AVERT.orgAVERT: The First Five YearsLiving with HIVLiving with HIV and AIDSAm I going to die?Emotional Needs and SupportHIV and PregnancyLearning You Are HIV PositiveLiving with HIV StoriesWhat is living with HIV?PreventionOverview of HIV preventionHIV Prevention Around the WorldIntroduction to HIV PreventionPrevention of HIV transmission from mother to childHIV Transmission from Mother-to-childPreventing Mother-to-child Transmission (PMTCT) in PracticePreventing Mother-to-child Transmission of HIV WHO Guidelines for PMTCT & BreastfeedingPrevention of HIV transmission through bloodBlood Safety and HIVNeedle Exchange and Harm ReductionPrevention of HIV Transmission through BloodAIDS and sex educationAbstinence and Sex EducationHIV Prevention through Sex EducationHIV/AIDS Education and Young PeopleIntroduction to HIV and AIDS EducationLessons and Activity PlansSex Education That WorksPrevention of sexual transmission of HIVCircumcision & HIVCondoms: Effectiveness, History and AvailabilityHIV Prevention StrategiesPrevention of Sexual Transmission of HIVSex Workers and HIV PreventionThe Female CondomUsing Condoms, Condom Types and SizesHIV treatment as preventionHIV Treatment As PreventionHIV Treatment for PreventionPost-exposure Prophylaxis Pre-exposure ProphylaxisScienceHIV scienceA Cure for AIDSA World Free from HIVHIV and AIDS VaccineHIV Causes AIDSHIV Drugs, Vaccines and Animal TestingHIV Structure and Life CycleHIV Types, Subtypes Groups and StrainsMicrobicidesThe Origin of HIV and AIDS StatisticsWorldwide HIV & AIDS StatisticsUnderstanding HIV and AIDS StatisticsWorldwide HIV & AIDS StatisticsWorldwide HIV & AIDS Statistics CommentaryAmerican HIV & AIDS StatisticsUnited States of America HIV & AIDS Statistics Canadian HIV & AIDS StatisticsCanada AIDS Statistics by Year and AgeCanada HIV Statistics SummaryLatin American & Caribbean HIV & AIDS StatisticsCaribbean HIV & AIDS StatisticsLatin America HIV & AIDS StatisticsAfrican HIV & AIDS StatisticsSouth Africa HIV & AIDS StatisticsSub-Saharan Africa HIV & AIDS StatisticsAsian HIV & AIDS StatisticsIndia HIV & AIDS StatisticsSouth East Asia HIV & AIDS StatisticsAustralian HIV & AIDS StatisticsAustralia HIV & AIDS StatisticsEuropean HIV & AIDS StatisticsEuropean HIV and AIDS StatisticsUK HIV and AIDS Statistics Transmission & Testing HIV transmissionAIDS: Fear and AnxietyCan You Get HIV From. . . ?Criminal Transmission of HIVHIV & AIDS SymptomsHIV and BreastfeedingHIV Transmission Questions & AnswersHIV testingHIV TestingHIV Testing Frequently Asked QuestionsTreatment & Care HIV and AIDS treatmentHIV and AIDS TreatmentHIV and AIDS Treatment & CareHIV Treatment for ChildrenStarting, monitoring & switching HIV treatmentHIV and AIDS care HIV and AIDS CareHIV and AIDS Home Based CareHIV/AIDS and PainPalliative CareHIV and AIDS drugsAntiretroviral Drug Side EffectsAntiretroviral Drugs TableHIV and AIDS DrugsNew Antiretroviral DrugsTreatment accessAIDS, Drug Prices and Generic DrugsTreatment AccessUniversal Access to HIV/AIDS TreatmentAIDS-related infectionsHIV Opportunistic Infections: Prevention and TreatmentHIV/AIDS & related InfectionsStages of HIV InfectionTuberculosisOther treatment and careAlternative and Traditional Medicine for HIVHIV and NutritionHIV & AIDS Around The World AfricaThe HIV & AIDS epidemic in AfricaGay Men in Africa and HIV/AIDSHIV and AIDS in AfricaHIV and AIDS in Africa QuestionsThe Impact of HIV & AIDS in AfricaAfrican countriesHIV & AIDS in BotswanaHIV & AIDS in MalawiHIV and AIDS in KenyaHIV and AIDS in NigeriaHIV and AIDS in South AfricaHIV and AIDS in SwazilandHIV and AIDS in TanzaniaHIV and AIDS in UgandaHIV and AIDS in ZambiaHIV and AIDS in ZimbabweHIV and AIDS in LesothoHistory of HIV & AIDS in AfricaHistory of HIV & AIDS in AfricaHistory of HIV & AIDS in South AfricaTimeline of AIDS in AfricaAmericasHIV & AIDS in the United StatesHistory of HIV & AIDS in the United States of AmericaHIV & AIDS in the United States of AmericaHIV & AIDS Treatment in the United States of AmericaHIV and AIDS Among African AmericansHelp and advice for HIV and AIDS in AmericaUSA HIV & AIDS Help and AdviceHIV & AIDS in Latin America and the CaribbeanHIV & AIDS in BrazilHIV and AIDS in Latin AmericaHIV and AIDS in the CaribbeanAsia & EuropeHIV & AIDS in AsiaHIV & AIDS in ChinaHIV & AIDS in ThailandHIV and AIDS in AsiaOverview of HIV and AIDS in IndiaTimeline of AIDS in AsiaWho is Affected by HIV and AIDS in India?HIV & AIDS in EuropeHistory of HIV & AIDS in the UK 1981-1995History of HIV & AIDS in the UK 1996 OnwardsHIV and AIDS in Russia, Eastern Europe & Central AsiaHIV and AIDS in the UKHIV and AIDS in Western and Central EuropeHIV and AIDS Treatment in the UKHelp and advice in the UKHelp and Advice for HIV/AIDS in the UKWho Has to Pay for NHS Treatment in the UK?Sex, Sexuality & Relationships Gay & LesbianGay & LesbianAm I Gay? Are You Born Gay? Can You Stop Being Gay?Coming outGay and LesbianGay SexHomophobia, Prejudice & Attitudes to Gay Men & LesbiansHomosexual or Gay?How Many Gay People Are There?Lesbians, Bisexual Women and Safe SexYoung & GayBeing Gay at SchoolHIV, AIDS and Young Gay MenGay & LesbianAm I a Lesbian?Am I Gay?Young Gay Men & LesbiansResources & helpResources for people who are gay, lesbian or unsure'Young Gay Men Talking' booklet [PDF]STDsCommon STDsChlamydia Genital Warts HPVGonorrhea Hepatitis A, B & CHerpes STD PicturesSTIs or STDsSyphilisSTD StatisticsSTD Statistics WorldwideSTDs in AmericaSTDs in the UKSexInformation about sex Condoms & Spermicides questionsContraception questionsHow to Have SexOral SexPregnancy QuestionsSex QuestionsWorldwide Ages of ConsentYoung PeopleRelationships & SexAm I Ready for Sex?Being Gay, Sexuality and Attraction Having SexHaving Sex for the First TimeRelationships and FeelingsRelationships and Sex Your Body and PubertyPuberty and Boys' BodiesPuberty, Periods and Girls' BodiesYour Body, Puberty and Sexual Organs Having Safer SexAbout HIV/AIDS for Young PeopleAbout STIs & STDs for Young PeopleBirth Control and Contraception for Young PeopleCondom Tips for Young PeopleDrink, Drugs & SexHaving Safer SexSex, the Internet and TechnologySex, the Law and Young PeopleHIV-positive LifeBeing HIV-positive and HealthyFinding Out That You're HIV-positiveFriends, Attitudes and HIVSex and Relationships for HIV-positive Young PeopleFAQ about sexQuestions About Sex for Young PeopleOther WebsitesGo Ask Alice!Sex, Etc.BBC - The SurgeryPhotos, Videos, Games & Stories Games Play our games to test your knowledge and skills, while learning new facts. See how much you know about HIV/AIDS and sexual health, with our AIDS Game, Sex Education Game, Pregnancy Game and Condom Game. Use your mouse to collect the right letters while avoiding the baddies for a chance to appear on our HI-scores table. Give our games a try now, and see how well you can do! AIDS Game Pregnancy Game Sex Education Game Condom Game Photos & Videos Our media gallery contains hundreds of HIV and AIDS related photos, videos and graphics. You can have a look around, use the search feature, or take a look at some photo selections. Photo Selections Photos & Videos Gallery Media Types Photos Graphics Videos Search the Media Gallery Latest media: Quizzes Try our quizzes to test your knowledge on all aspects of sexual health and HIV and AIDS. We have a Sex Quiz, Pregnancy Quiz, Condom Quiz and an HIV and AIDS Quiz. Just a beginner? Then try the quizzes' easy levels. Think you're an expert? Well try the hard quizzes. AIDS Challenge HIV and AIDS Quiz Pregnancy Quiz Sex Education Quiz Condom Quiz StoriesLesbian and gay storiesComing out StoriesYoung Bisexual and Gay Men: Personal StoriesYoung Lesbian and Bisexual: Personal StoriesHIV and AIDSHIV and AIDS in the FamilyPersonal Stories of Men Living with HIVPersonal Stories of Women Living with HIVPersonal Stories of Young People Living with HIVStories From Around the WorldTalking about sex First Time Sex StoriesStories of Sex EducationSubmit a storyFeatured Story I went through kind of a phase shift from just getting feelings towards this one guy, to be being confused and feeling kind of bi... - Submitted by Wesley Read more >> InternationalYouth Day 2013 Involving youth in the HIV response Giving young people a platform to share their thoughts and experiences raises awareness among their peers and gives an invaluable insight into the needs of this high-risk group. More than 2,400 young people are newly infected with HIV every day, accounting for 40% of new adult infections. Involving youth in the HIV response is key to lowering new HIV infections among the next generation and the role of technology in doing this is now clearer than ever. A sneak preview of results from an AVERT survey, due to be released on International Youth Day 2013 - 12 August, show that most young people prefer to get their sexual health and HIV/AIDS information online or via mobile, as it's quicker, confidential and cheap. But not all youth are the same, we've found regional variations in the type of technology young people prefer - with 67% of respondents from Africa using mobile phones for health information, compared to just 31% in Europe. To commemorate International Youth Day 2013 - 12 August, share your experiences with others by sending AVERT your story. Raise HIV awareness among youth, check out the hints, tips and quizzes below and share them with your friends. Young People Zone Quizzes 'Can't Explain' home pageTemas sobre el VIH y el SIDA ¿Puede Contraer SIDA De. . . ?Síntomas Del VIH Y Del SIDASIDAVIHPruebas De Detección Del VIHVIH, Embarazo, Madres Y BebésVisión General De La Prevención De VIHIntroducción Al Tratamiento De VIH Y SIDALa Evidencia De Que El VIH Causa El SIDALas Estadísticas Del SIDA Y VIH En El MundoSexo, sexualidad y las relaciones ¿Cómo Se Tiene Sexo?Preguntas Generales Sobre SexoUso De Condones, Tipos Y Tamaños De Condones¿Soy Gay? ¿Se Nace Gay? ¿Se Puede Dejar De Ser Gay?Enfermedades De Transmisión Sexual Y Síntomas De ETSMedia, juegos y concursos Fotos y VideosJuegos (en Inglés) Search Avert.org Click to search site search back to content
People with HIV can live long and healthy lives with access to treatment. Since HIV was first reported substantial progress in the research and development of antiretroviral drugs has been made. There are now more than 20 approved antiretroviral drugs. Despite this, people with HIV face many barriers to accessing affordable, effective HIV treatment.
Taking HIV treatment requires effort and commitment as drugs must be taken at exact times each day. Some people may experience serious side-effects or may not respond to certain drugs. Treatment, care and support can help people to adhere to treatment and address any problems they may have with their treatment regimen.
This page points to comprehensive information about the antiretroviral drugs used to treat HIV, what is involved when a person begins taking antiretroviral treatment and the global disparities in access to treatment.
This is the main type of treatment for HIV or AIDS. It is not a cure, but it can stop people from becoming ill for many years. The treatment consists of drugs that have to be taken every day for the rest of a person’s life.
The aim of antiretroviral treatment is to keep the amount of HIV in the body at a low level. This stops any weakening of the immune system and allows it to recover from any damage that HIV might have caused already.
The drugs are often referred to as: antiretrovirals, ARVs, anti-HIV or anti-AIDS drugs.
Taking two or more antiretroviral drugs at a time is called combination therapy. Taking a combination of three or more anti-HIV drugs is sometimes referred to as Highly Active Antiretroviral Therapy (HAART).
If only one drug was taken, HIV would quickly become resistant to it and the drug would stop working. Taking two or more antiretrovirals at the same time vastly reduces the rate at which resistance would develop, making treatment more effective in the long term. Our starting, monitoring and switching HIV treatment page has more about drug resistance.
The most common drug combination given to those beginning treatment consists of two NRTIs combined with either an NNRTI or a "boosted" protease inhibitor. Ritonavir (in small doses) is most commonly used as the booster; it enhances the effects of other protease inhibitors so they can be given in lower doses. An example of a common antiretroviral combination is the two NRTIs zidovudine and lamivudine, combined with the NNRTI efavirenz.
Some antiretroviral drugs have been combined into one pill, which is known as a ‘fixed dose combination’. This reduces the number of pills to be taken each day.
The choice of drugs to take can depend on a number of factors, including the availability and price of drugs, the number of pills, the side effects of the drugs, the laboratory monitoring requirements and whether there are co-blister packs or fixed dose combinations available. Most people living with HIV in the developing world still have very limited access to antiretroviral treatment and often only receive treatment for the diseases that occur as a result of a weakened immune system. Such treatment has only short-term benefits because it does not address the underlying immune deficiency itself.
At the beginning of treatment, the combination of drugs that a person is given is called first line therapy. If after a while HIV becomes resistant to this combination, or if side effects are particularly bad, then a change to second line therapy is usually recommended.
Second line therapy will ideally include a minimum of three new drugs, with at least one from a new class, in order to increase the likelihood of treatment success.
Our starting, monitoring and switching HIV treatment page has more information about changing HIV treatment.
There are more than 20 approved antiretroviral drugs but not all are licensed or available in every country. See our drugs table for a comprehensive list of antiretroviral drugs approved by the American Food and Drug Administration.
There are five groups of antiretroviral drugs. Each of these groups attacks HIV in a different way.
NRTIs and NNRTIs are available in most countries. Fusion/entry inhibitors and integrase inhibitors are usually only available in resource-rich countries.
Protease inhibitors are generally less suitable for starting treatment in resource-limited settings due to the cost, number of pills which need to be taken, and the particular side effects caused by protease drugs.
Choosing when to start antiretroviral treatment is a very important decision. Once treatment has begun it must be adhered to, in spite of side effects and other challenges. Many factors must be weighed up when deciding whether to begin treatment, including the results of various clinical tests. These issues are addressed in our starting, monitoring and switching HIV treatment page.
www.avert.org is an information resource to be used for educational purposes only. The information is not intended to serve as a substitute for professional medical advice and we recommend that all decisions about your treatment or products you wish to use should be discussed thoroughly and frankly with your doctor.
english español
Play our games to test your knowledge and skills, while learning new facts. See how much you know about HIV/AIDS and sexual health, with our AIDS Game, Sex Education Game, Pregnancy Game and Condom Game. Use your mouse to collect the right letters while avoiding the baddies for a chance to appear on our HI-scores table.
Give our games a try now, and see how well you can do!
Our media gallery contains hundreds of HIV and AIDS related photos, videos and graphics. You can have a look around, use the search feature, or take a look at some photo selections.
Try our quizzes to test your knowledge on all aspects of sexual health and HIV and AIDS. We have a Sex Quiz, Pregnancy Quiz, Condom Quiz and an HIV and AIDS Quiz.
Just a beginner? Then try the quizzes' easy levels. Think you're an expert? Well try the hard quizzes.
I went through kind of a phase shift from just getting feelings towards this one guy, to be being confused and feeling kind of bi... - Submitted by Wesley Read more >>
Giving young people a platform to share their thoughts and experiences raises awareness among their peers and gives an invaluable insight into the needs of this high-risk group. More than 2,400 young people are newly infected with HIV every day, accounting for 40% of new adult infections.
Involving youth in the HIV response is key to lowering new HIV infections among the next generation and the role of technology in doing this is now clearer than ever.
A sneak preview of results from an AVERT survey, due to be released on International Youth Day 2013 - 12 August, show that most young people prefer to get their sexual health and HIV/AIDS information online or via mobile, as it's quicker, confidential and cheap. But not all youth are the same, we've found regional variations in the type of technology young people prefer - with 67% of respondents from Africa using mobile phones for health information, compared to just 31% in Europe.
To commemorate International Youth Day 2013 - 12 August, share your experiences with others by sending AVERT your story. Raise HIV awareness among youth, check out the hints, tips and quizzes below and share them with your friends.